27.02.2017 14:00:00

ChineseInvestors.com Presents at Yibao Biologics' Annual Conference, Optimistic About Direct Selling Opportunity in China

NEW YORK, Feb.  27, 2017 /PRNewswire/ -- ChineseInvestors.com (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces that company CEO Warren Wang attended Shangdong Yibao Biologics Co. Ltd.'s annual conference, and, by invitation, delivered a five-minute speech to celebrate the 18th anniversary of Yibao Biologics.

Yibao Biologics is a modern high-tech enterprise which specializes in the research, production and sales of chondroitin sulfate series and Confucian series health care products. The company is also the largest and most professional manufacturer of chondroitin sulfate in the world. Yibao Biologics invited ChineseInvestors.com to participate in its annual direct sales conference to discuss the development and prospects of Chinese health products enterprises in the United States.

As an attendee of the conference, Wang learned how direct sales of the health products industry operate in China, and how to apply this information to build the sales team of CIIX's ChineseCBDoil.com retail website. He also delivered a five-minute speech at the conference and received continuous applause from more than 5,000 direct sales persons in attendance.

"The market for direct selling of natural products in the United States has considerable depth, and varies from the Chinese market in many ways. It was an honor to attend this year's Yibao Biologics conference, where I was able to gain valuable market insight as well as present my own expertise to fellow attendees," says Wang.

ChineseInvestors.com recently launched www.ChineseCBDoil.com, marking the company's official entry into the CBD hemp oil markets.

"ChineseInvestors.com will continue to sell CBD health products through online retailing methods to the world's nearly 1.4 billion Chinese people. Additionally, we will gradually open offline selling channels and combine word-of-mouth marketing with Internet retailing. Our goal is to benefit more Chinese people with reliable logistics network and commodity channels, as well as to provide leading positions in products and resources. Due to the huge size of the Chinese direct selling market, we hope to further expand our market share through investment and alliance in and with direct selling companies," concludes Wang.

About ChineseInvestors.com (OTCQB: CIIX) 

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) support services to our various partners; (c) consulting services to smaller private companies considering becoming a public company; and (d) advertising and public relation related support services.

For more information visit www.ChineseInvestors.com

Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom

Follow us on Twitter for real-time Company updates: https://twitter.com/ChineseFNEnglsh

Like us on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom

Add us on WeChat at: Chinesefn or download iPhone iOS App: Chinesefn.

Contact:
Chineseinvestors.com Inc.
14 Wall Street, Suite 2038
New York, NY 10005

Investor Relations:
Alan Klitenic
+1-(214)-636-2548

Corporate Communications:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com   
+1-(212)-418-1217 Office   
editor@NetworkNewsWire.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/chineseinvestorscom-presents-at-yibao-biologics-annual-conference-optimistic-about-direct-selling-opportunity-in-china-300413832.html

SOURCE ChineseInvestors.com

Nachrichten zu Chnieseinvestors.com Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Chnieseinvestors.com Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!